Latest Production Development News

ARB Corporation Limited posted a 5.9% rise in sales revenue to $361.7 million for 1H FY2025, driven by strong export growth, while profit before tax edged down 0.7% amid rising costs and subdued domestic vehicle sales.

Infomedia Limited has announced an on-market share buyback of up to 5% of its issued capital, signalling confidence in its financial strength and commitment to shareholder value. The buyback will be executed over the next 12 months, leveraging the company’s robust cash reserves.

Icetana Limited has successfully closed its renounceable pro rata entitlement offer, raising $629,422 through new share issuance, with convertible notes poised to convert into shares shortly.

Toys"R"Us ANZ has entered a strategic three-year partnership with Directed Electronics Australia to co-develop private label products and enhance marketing capabilities, marking a pivotal step in its growth strategy.

GWA Group Limited reported a 1.9% revenue increase and a 3.2% rise in normalized EBIT for the half year ended December 2024, alongside a 7.1% lift in its interim dividend, reflecting disciplined execution despite tough market conditions.

Audinate Group Limited's half-year results reveal a sharp 38.4% revenue decline and a $2.2 million net loss, driven by reduced chip demand as customers clear inventory. Yet, growth in OEM partnerships hints at potential recovery.

Osteopore Limited has drawn down A$2 million from the first tranche of its redeemable convertible notes, using the proceeds to repay existing loans and support ongoing business activities.

Artrya Limited has launched a A$15 million capital raising to fund the development and commercial rollout of its Salix AI-powered coronary artery disease diagnostic platform, targeting the lucrative US healthcare market.

Cochlear Limited posted a 5% increase in sales revenue to $1.17 billion for the half year ended December 2024, driven by strong cochlear and acoustic implant growth despite a decline in Services revenue. The company anticipates FY25 underlying net profit at the lower end of guidance amid increased cloud investments and prepares for new product launches.

Neurotech International has inked a development deal with RH Farma to produce a pharmaceutical-grade cannabinoid drug targeting pediatric neurodevelopmental disorders, leveraging advanced European extraction technology.

Micro-X Ltd has launched the retail component of its $6 million capital raising, offering eligible shareholders the chance to buy new shares at 7 cents each, aiming to raise $2.7 million by late February 2025.

Echo IQ has secured a $1.26 million refund under the Australian Government's R&D Tax Incentive, reinforcing its commitment to AI-driven solutions for structural heart disease detection.